My Portfolio

Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD

After Hours: Last | 7:56 PM EDT

48.73

-0.33 (-0.67%)

Volume

217,491

49.06

+3.42 (+7.49%)

Volume

6,674,885

52 week range

22.28 - 59.55

Open45.30
Day High49.55
Day Low45.30
Prev Close45.64
52 Week High59.55
52 Week High Date03/04/26
52 Week Low22.28
52 Week Low Date11/21/25

Latest On Moderna Inc

Pfizer CEO Albert Bourla on the company's oncology focusJune 2, 2026CNBC.com
Moderna CEO Stephane Bancel on INT trial results: There's duration of efficacy which is excitingJune 1, 2026CNBC.com
Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to knowMay 27, 2026CNBC.com
Cramer’s Stop Trading: Zoom CommunicationsMay 19, 2026CNBC.com
25. Lila SciencesMay 19, 2026CNBC.com
Hantavirus isn't another Covid, but experts say it's testing U.S. readinessMay 14, 2026CNBC.com
FDA head resigning boosts healthcare stocks short-term, but still a lot of unknowns: Mizuho's HolzMay 12, 2026CNBC.com
Trump says Makary resigns as FDA commissioner following backlashMay 12, 2026CNBC.com
CNBC Markets Now: May 11, 2026May 11, 2026CNBC.com
Stocks making the biggest moves midday: Corning, Qualcomm, Wendy’s & moreMay 11, 2026CNBC.com

Key Stats

Market Cap19.466B
Shares Out396.79M
10 Day Average Volume4.98M
Dividend-
Dividend Yield-
Beta1.03

Latest On Moderna Inc

Pfizer CEO Albert Bourla on the company's oncology focusJune 2, 2026CNBC.com
Moderna CEO Stephane Bancel on INT trial results: There's duration of efficacy which is excitingJune 1, 2026CNBC.com
Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to knowMay 27, 2026CNBC.com
Cramer’s Stop Trading: Zoom CommunicationsMay 19, 2026CNBC.com
25. Lila SciencesMay 19, 2026CNBC.com
Hantavirus isn't another Covid, but experts say it's testing U.S. readinessMay 14, 2026CNBC.com
FDA head resigning boosts healthcare stocks short-term, but still a lot of unknowns: Mizuho's HolzMay 12, 2026CNBC.com
Trump says Makary resigns as FDA commissioner following backlashMay 12, 2026CNBC.com
CNBC Markets Now: May 11, 2026May 11, 2026CNBC.com
Stocks making the biggest moves midday: Corning, Qualcomm, Wendy’s & moreMay 11, 2026CNBC.com

KEY STATS

Open45.30
Day High49.55
Day Low45.30
Prev Close45.64
52 Week High59.55
52 Week High Date03/04/26
52 Week Low22.28
52 Week Low Date11/21/25
Market Cap19.466B
Shares Out396.79M
10 Day Average Volume4.98M
Dividend-
Dividend Yield-
Beta1.03

RATIOS/PROFITABILITY

EPS (TTM)-8.15
P/E (TTM)-6.02
Fwd P/E (NTM)-7.01
EBITDA (TTM)-2.89B
ROE (TTM)-36.56%
Revenue (TTM)2.225B
Gross Margin (TTM)35.01%
Net Margin (TTM)-143.55%
Debt To Equity (MRQ)8.56%

EVENTS

Earnings Date07/30/2026(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Content From Our Affiliates

Barclays Sticks to Their Hold Rating for Moderna (MRNA)17 Hours AgoTipRanks
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Mediwound (MDWD)June 2, 2026TipRanks
Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (LH), Moderna (MRNA) and Celcuity (CELC)June 2, 2026TipRanks
FDA issues draft guidance to help accelerated cell, gene therapies for patientsJune 2, 2026TipRanks
Analysts Conflicted on These Healthcare Names: BeOne Medicines (ONC), Moderna (MRNA) and Danaher (DHR)June 2, 2026TipRanks

Profile

Moderna, Inc. is a biotechnology company advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is engaged in developing medicines across infectious disease vaccines, oncology therapeutics and rare disease therapeutics. Its platform incorporates advances across three components, mRNA, delivery, and the manufacturing process, to advance its medicines. Its products are Spikevax and mNEXSPIKE (its COVID vaccines), and mRESVIA (its vaccine against...

Noubar Afeyan Ph.D.

Independent Chairman of the Board, Co-Founder

Stephane Bancel

Chief Executive Officer, Director

Stephen Hoge M.D.

President

Jerh Collins

Chief Technical Operations and Quality Officer

James Mock

Chief Financial Officer

Rose Loughlin Ph.D.

Executive Vice President - Research

Address

325 BINNEY STREET

Cambridge, MA

02142

United States

https://www.modernatx.com/